The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
138 - In your answer to Question 137, you are saying that although it goes beyond name, price & quantity, the PM (in its entirety)is not considered advertising. So is it acceptable to link the PM to the banner ad in the consumer realm?
DTCA/I, consumer secondary audience
1
Posts
1
Posters
324
Views
1
Watching
-
No. Because the product monograph contains content which goes beyond the name, price & quantity restriction, it may not be linked to advertising (e.g. a banner ad). For the product monograph not to be considered "advertising" it must be complete/unchanged AND it must not be linked to advertising (e.g. a banner ad). Health Canada had confirmed that linking the product monograph to a banner ad in a consumer realm would contravene C.01.044 of the Food and Drugs Regulations. Please call the PAAB if you have further questions about this.
